CORESTATE CAPITAL EO-,075/ LU1296758029 /
6/14/2024 8:03:07 AM | Chg. -0.008 | Volume | Bid1:17:23 PM | Ask1:17:23 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
0.592EUR | -1.33% | - Turnover: - |
0.590Bid Size: 3,000 | 0.626Ask Size: 3,000 | 14.34 mill.EUR | 0.00% | - |
GlobeNewswire
2:45 PM
OneMedNet Partners with Leading Clinical Trial Design and Software Company in Significant Data Licen...
GlobeNewswire
2:45 PM
Monte Rosa Therapeutics Presents Preclinical Data at EULAR 2024 Demonstrating Therapeutic Potential ...
GlobeNewswire
2:39 PM
SECU Awarded PLANSPONSOR of the Year for Its Total Retirement Offering for Employees
GlobeNewswire
2:30 PM
SRIVARU (SVMH) Announces PRANA 2.0 Electric Motorbike will be Available to Order Online Beginning Ju...
GlobeNewswire
2:30 PM
Golden Triangle Ventures Announces Launch of Its Freight Brokerage Division with Full Financial Supp...
GlobeNewswire
2:30 PM
Chijet Motor Company, Inc.’s Subsidiary Entered Into Framework Cooperation Agreement with Uzbekistan...
GlobeNewswire
2:30 PM
FOXO Technologies Enters into Share Exchange Agreements to Acquire Healthcare Operations from Rennov...
GlobeNewswire
2:10 PM
Diana Shipping Inc. Announces Time Charter Contract for m/v Myrsini With Cobelfret S.A.
GlobeNewswire
2:03 PM
ElmediX Plans Series A Round Based on Strong Signals in a Clinical Study for Pancreatic Cancer Patie...
GlobeNewswire
2:00 PM
Jasper Therapeutics Presents Data from Preclinical Briquilimab Study at the 2024 EHA Hybrid Congress
GlobeNewswire
2:00 PM
BIO-key Introduces Passkey:YOU, a Phish-resistant, Phoneless and Tokenless Biometric FIDO Passkey Au...
GlobeNewswire
2:00 PM
Mineralys Therapeutics Appoints Biopharmaceutical Executive Alexander M. Gold, M.D. to its Board of ...